The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Inhalation Anesthetic-Global Market Insights and Sales Trends 2024
Synopsis
The global Inhalation Anesthetic market size is expected to reach US$ 1524.1 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Inhalation Anesthetic in various end use industries. The expanding demands from the Hospital Use and Clinic Use, are propelling Inhalation Anesthetic market. Sevoflurane, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Isoflurane segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Inhalation Anesthetic market, driven by demand from China, the second largest economy with some signs of stabilising, the Inhalation Anesthetic market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inhalation Anesthetic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inhalation Anesthetic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inhalation Anesthetic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inhalation Anesthetic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inhalation Anesthetic covered in this report include AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals and Mylan, etc.
The global Inhalation Anesthetic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui
Anesthesia Reclamation
Deltasorb Technologies (Blue Zone Technology)
Global Inhalation Anesthetic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inhalation Anesthetic market, Segment by Type:
Sevoflurane
Isoflurane
Desflurane
Others
Global Inhalation Anesthetic market, by Application
Hospital Use
Clinic Use
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Inhalation Anesthetic manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Inhalation Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Inhalation Anesthetic market size is expected to reach US$ 1524.1 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Inhalation Anesthetic in various end use industries. The expanding demands from the Hospital Use and Clinic Use, are propelling Inhalation Anesthetic market. Sevoflurane, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Isoflurane segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Inhalation Anesthetic market, driven by demand from China, the second largest economy with some signs of stabilising, the Inhalation Anesthetic market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inhalation Anesthetic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inhalation Anesthetic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inhalation Anesthetic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inhalation Anesthetic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inhalation Anesthetic covered in this report include AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals and Mylan, etc.
The global Inhalation Anesthetic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui
Anesthesia Reclamation
Deltasorb Technologies (Blue Zone Technology)
Global Inhalation Anesthetic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inhalation Anesthetic market, Segment by Type:
Sevoflurane
Isoflurane
Desflurane
Others
Global Inhalation Anesthetic market, by Application
Hospital Use
Clinic Use
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Inhalation Anesthetic manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Inhalation Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Inhalation Anesthetic Market Overview
1.1 Inhalation Anesthetic Product Overview
1.2 Inhalation Anesthetic Market Segment by Type
1.2.1 Sevoflurane
1.2.2 Isoflurane
1.2.3 Desflurane
1.2.4 Others
1.3 Global Inhalation Anesthetic Market Size by Type
1.3.1 Global Inhalation Anesthetic Market Size Overview by Type (2018-2029)
1.3.2 Global Inhalation Anesthetic Historic Market Size Review by Type (2018-2023)
1.3.3 Global Inhalation Anesthetic Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inhalation Anesthetic Sales Breakdown by Type (2018-2023)
1.4.2 Europe Inhalation Anesthetic Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Inhalation Anesthetic Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Inhalation Anesthetic Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Inhalation Anesthetic Sales Breakdown by Type (2018-2023)
2 Global Inhalation Anesthetic Market Competition by Company
2.1 Global Top Players by Inhalation Anesthetic Sales (2018-2023)
2.2 Global Top Players by Inhalation Anesthetic Revenue (2018-2023)
2.3 Global Top Players by Inhalation Anesthetic Price (2018-2023)
2.4 Global Top Manufacturers Inhalation Anesthetic Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inhalation Anesthetic Market Competitive Situation and Trends
2.5.1 Inhalation Anesthetic Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Inhalation Anesthetic Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inhalation Anesthetic as of 2022)
2.7 Date of Key Manufacturers Enter into Inhalation Anesthetic Market
2.8 Key Manufacturers Inhalation Anesthetic Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inhalation Anesthetic Status and Outlook by Region
3.1 Global Inhalation Anesthetic Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Inhalation Anesthetic Historic Market Size by Region
3.2.1 Global Inhalation Anesthetic Sales in Volume by Region (2018-2023)
3.2.2 Global Inhalation Anesthetic Sales in Value by Region (2018-2023)
3.2.3 Global Inhalation Anesthetic Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Inhalation Anesthetic Forecasted Market Size by Region
3.3.1 Global Inhalation Anesthetic Sales in Volume by Region (2024-2029)
3.3.2 Global Inhalation Anesthetic Sales in Value by Region (2024-2029)
3.3.3 Global Inhalation Anesthetic Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Inhalation Anesthetic by Application
4.1 Inhalation Anesthetic Market Segment by Application
4.1.1 Hospital Use
4.1.2 Clinic Use
4.2 Global Inhalation Anesthetic Market Size by Application
4.2.1 Global Inhalation Anesthetic Market Size Overview by Application (2018-2029)
4.2.2 Global Inhalation Anesthetic Historic Market Size Review by Application (2018-2023)
4.2.3 Global Inhalation Anesthetic Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inhalation Anesthetic Sales Breakdown by Application (2018-2023)
4.3.2 Europe Inhalation Anesthetic Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Inhalation Anesthetic Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Inhalation Anesthetic Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Inhalation Anesthetic Sales Breakdown by Application (2018-2023)
5 North America Inhalation Anesthetic by Country
5.1 North America Inhalation Anesthetic Historic Market Size by Country
5.1.1 North America Inhalation Anesthetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Inhalation Anesthetic Sales in Volume by Country (2018-2023)
5.1.3 North America Inhalation Anesthetic Sales in Value by Country (2018-2023)
5.2 North America Inhalation Anesthetic Forecasted Market Size by Country
5.2.1 North America Inhalation Anesthetic Sales in Volume by Country (2024-2029)
5.2.2 North America Inhalation Anesthetic Sales in Value by Country (2024-2029)
6 Europe Inhalation Anesthetic by Country
6.1 Europe Inhalation Anesthetic Historic Market Size by Country
6.1.1 Europe Inhalation Anesthetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Inhalation Anesthetic Sales in Volume by Country (2018-2023)
6.1.3 Europe Inhalation Anesthetic Sales in Value by Country (2018-2023)
6.2 Europe Inhalation Anesthetic Forecasted Market Size by Country
6.2.1 Europe Inhalation Anesthetic Sales in Volume by Country (2024-2029)
6.2.2 Europe Inhalation Anesthetic Sales in Value by Country (2024-2029)
7 Asia-Pacific Inhalation Anesthetic by Region
7.1 Asia-Pacific Inhalation Anesthetic Historic Market Size by Region
7.1.1 Asia-Pacific Inhalation Anesthetic Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Inhalation Anesthetic Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Inhalation Anesthetic Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Inhalation Anesthetic Forecasted Market Size by Region
7.2.1 Asia-Pacific Inhalation Anesthetic Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Inhalation Anesthetic Sales in Value by Region (2024-2029)
8 Latin America Inhalation Anesthetic by Country
8.1 Latin America Inhalation Anesthetic Historic Market Size by Country
8.1.1 Latin America Inhalation Anesthetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Inhalation Anesthetic Sales in Volume by Country (2018-2023)
8.1.3 Latin America Inhalation Anesthetic Sales in Value by Country (2018-2023)
8.2 Latin America Inhalation Anesthetic Forecasted Market Size by Country
8.2.1 Latin America Inhalation Anesthetic Sales in Volume by Country (2024-2029)
8.2.2 Latin America Inhalation Anesthetic Sales in Value by Country (2024-2029)
9 Middle East and Africa Inhalation Anesthetic by Country
9.1 Middle East and Africa Inhalation Anesthetic Historic Market Size by Country
9.1.1 Middle East and Africa Inhalation Anesthetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Inhalation Anesthetic Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Inhalation Anesthetic Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Inhalation Anesthetic Forecasted Market Size by Country
9.2.1 Middle East and Africa Inhalation Anesthetic Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Inhalation Anesthetic Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Inhalation Anesthetic Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Fresenius-Kabi
10.2.1 Fresenius-Kabi Company Information
10.2.2 Fresenius-Kabi Introduction and Business Overview
10.2.3 Fresenius-Kabi Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Fresenius-Kabi Inhalation Anesthetic Products Offered
10.2.5 Fresenius-Kabi Recent Development
10.3 BbVie Laboratories
10.3.1 BbVie Laboratories Company Information
10.3.2 BbVie Laboratories Introduction and Business Overview
10.3.3 BbVie Laboratories Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BbVie Laboratories Inhalation Anesthetic Products Offered
10.3.5 BbVie Laboratories Recent Development
10.4 Baxter Healthcare
10.4.1 Baxter Healthcare Company Information
10.4.2 Baxter Healthcare Introduction and Business Overview
10.4.3 Baxter Healthcare Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Baxter Healthcare Inhalation Anesthetic Products Offered
10.4.5 Baxter Healthcare Recent Development
10.5 Braun
10.5.1 Braun Company Information
10.5.2 Braun Introduction and Business Overview
10.5.3 Braun Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Braun Inhalation Anesthetic Products Offered
10.5.5 Braun Recent Development
10.6 Maruishi
10.6.1 Maruishi Company Information
10.6.2 Maruishi Introduction and Business Overview
10.6.3 Maruishi Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Maruishi Inhalation Anesthetic Products Offered
10.6.5 Maruishi Recent Development
10.7 Piramal Healthcare
10.7.1 Piramal Healthcare Company Information
10.7.2 Piramal Healthcare Introduction and Business Overview
10.7.3 Piramal Healthcare Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Piramal Healthcare Inhalation Anesthetic Products Offered
10.7.5 Piramal Healthcare Recent Development
10.8 Hikma Pharmaceuticals
10.8.1 Hikma Pharmaceuticals Company Information
10.8.2 Hikma Pharmaceuticals Introduction and Business Overview
10.8.3 Hikma Pharmaceuticals Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hikma Pharmaceuticals Inhalation Anesthetic Products Offered
10.8.5 Hikma Pharmaceuticals Recent Development
10.9 Mylan
10.9.1 Mylan Company Information
10.9.2 Mylan Introduction and Business Overview
10.9.3 Mylan Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mylan Inhalation Anesthetic Products Offered
10.9.5 Mylan Recent Development
10.10 Nhwa
10.10.1 Nhwa Company Information
10.10.2 Nhwa Introduction and Business Overview
10.10.3 Nhwa Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Nhwa Inhalation Anesthetic Products Offered
10.10.5 Nhwa Recent Development
10.11 Lunan
10.11.1 Lunan Company Information
10.11.2 Lunan Introduction and Business Overview
10.11.3 Lunan Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Lunan Inhalation Anesthetic Products Offered
10.11.5 Lunan Recent Development
10.12 Hengrui
10.12.1 Hengrui Company Information
10.12.2 Hengrui Introduction and Business Overview
10.12.3 Hengrui Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Hengrui Inhalation Anesthetic Products Offered
10.12.5 Hengrui Recent Development
10.13 Anesthesia Reclamation
10.13.1 Anesthesia Reclamation Company Information
10.13.2 Anesthesia Reclamation Introduction and Business Overview
10.13.3 Anesthesia Reclamation Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Anesthesia Reclamation Inhalation Anesthetic Products Offered
10.13.5 Anesthesia Reclamation Recent Development
10.14 Deltasorb Technologies (Blue Zone Technology)
10.14.1 Deltasorb Technologies (Blue Zone Technology) Company Information
10.14.2 Deltasorb Technologies (Blue Zone Technology) Introduction and Business Overview
10.14.3 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Products Offered
10.14.5 Deltasorb Technologies (Blue Zone Technology) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inhalation Anesthetic Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inhalation Anesthetic Industrial Chain Analysis
11.4 Inhalation Anesthetic Market Dynamics
11.4.1 Inhalation Anesthetic Industry Trends
11.4.2 Inhalation Anesthetic Market Drivers
11.4.3 Inhalation Anesthetic Market Challenges
11.4.4 Inhalation Anesthetic Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inhalation Anesthetic Distributors
12.3 Inhalation Anesthetic Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
